About the Anti-PD-1 Studies

Nivolumab Clinical Research Studies

Clinical research studies are now enrolling for the investigational compound nivolumab (BMS-936558) in certain cancer types. Click on one or more of the options to see if there is a participating study site in your area that you can contact directly.

Renal Cell Carcinoma (Kidney Cancer)

Lung Cancer


Please check back for future updates on melanoma studies.

Colon Cancer

Select Advanced Solid Tumors

Glioblastoma (Brain Cancer)

Head and Neck Cancer

  • Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)

Non-Hodgkin Lymphoma (DLBCL)

  • Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)

Non-Hodgkin Lymphoma (Follicular)

  • Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)

Hodgkin Lymphoma

Please note, not all studies may be enrolling at this time. Check back often for updates.